CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) AS AT AND FOR THREE MONTH PERIOD ENDED 30 SEPTEMBER 2025 (FIRST QUARTER)
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Third Quarter)
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) AS AT AND FOR THREE MONTH PERIOD ENDED 30 SEPTEMBER 2024 (FIRST QUARTER)
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) AS AT AND FOR NINE MONTH PERIOD ENDED 31 MARCH 2024 (Third Quarter)
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) AS AT AND FOR THREE MONTH PERIOD ENDED 30 SEPTEMBER 2023 (FIRST QUARTER)
|
© 2025 Orion Pharma Ltd. All rights reserved.